The platform trial: an efficient strategy for evaluating multiple treatments.
about
Cognitive behavioral therapy for suicidal behaviors: improving patient outcomesViral Infections and Obesity.PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.A multimodal approach to dementia prevention: A report from the Cambridge Institute of Public Health.Comorbidity in older adults with cancer.PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description.A path to precision in the ICU.Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?Efficiencies of platform clinical trials: A vision of the future.The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.The pragmatic clinical trial in a learning health care system.Ebola clinical trials: Five lessons learned and a way forward.MIDAS: a practical Bayesian design for platform trials with molecularly targeted agents.Talking to the people that really matter about their participation in pandemic clinical research: A qualitative study in four European countries.The Range and Scientific Value of Randomized Trials.Finding the precision to improve outcome in patients after cardiac arrest.Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illnessAdding experimental arms to platform clinical trials: randomization procedures and interim analyses.Personalised fluid resuscitation in the ICU: still a fluid concept?Seven unconfirmed ideas to improve future ICU practice.University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (afternoon panel discussion).A simulation study of outcome adaptive randomization in multi-arm clinical trials.Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research.A computable phenotype for asthma case identification in adult and pediatric patients: External validation in the Chicago Area Patient-Outcomes Research Network (CAPriCORN).Exploratory trials in mental health: anything to learn from other disciplines?New perspectives to improve critical care benchmarking.The Real-World Ethics of Adaptive-Design Clinical Trials.A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated studArguing for Adaptive Clinical Trials in Sepsis.Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC E): the ALIC E protocol
P2860
Q26752788-9BEBDDF0-8AB2-4045-B5F5-AE434CA382AFQ30235298-527A8019-9C6E-476C-A100-269D687B549CQ36040742-1DEF399B-3A44-4F73-A6BE-3DA80AD2188BQ36572536-135829D8-A8D7-476D-801C-9C1A5C2D34BEQ37029899-01D03AAE-930C-4283-A1AC-ADCABFDA5B21Q37481946-143E695B-4142-48D7-84A0-941BA60F8307Q37722642-D4BE5282-AD1B-4F2C-B99A-BB40610D8089Q37733894-C376650B-50B4-471E-B8CD-77FF9AA65D73Q38731482-4CC80F14-2A0E-4371-B42B-9B14AB18BE0AQ38904226-A58091CF-B52C-45A6-AFF7-A60BBC8F56DBQ38977208-1FE282C6-646A-4449-9BEE-A700E7D0827BQ39640855-54E6A6F2-B6C9-44AC-B390-780F3D1965C9Q40122803-069E642C-1652-4148-A3A0-D6D55FDA90DDQ41662421-C80513A3-4AAF-4C5D-AEDA-BEAE761B283DQ41928108-F358B8A6-487F-4087-AF5E-CF93703C3788Q42379773-9E25EE41-FDF6-48C0-8144-B8E7F56666C2Q42654557-5032A569-1EC5-4D8A-BCFF-9C519AB329ABQ42659568-1D629792-A9C2-4386-ACB4-BE3224CEF8C4Q45304949-243AD7C3-ABFB-451A-B7A8-C8AE159AF6BCQ47123669-ECF8A4F9-325D-400D-B814-1D9628787594Q47136454-3C83B73E-A3F1-4DE7-98BD-3290255707C2Q47304892-40BD2C5D-0478-42F2-AE1E-9E0FA8E46E75Q47316068-3C1294AE-829D-4F13-BA4A-26B6A6E83920Q47625359-2CE124FC-B200-4062-8E36-EE31A3A6C120Q47652180-58B39F9E-5423-413D-AC36-8A83949277ECQ47832169-61DE0193-9DEA-4982-B243-95BA03F90E1BQ49356234-4702595B-1784-453C-B501-F790928B2F3CQ49685098-A1028ADC-9818-4A1B-8386-C5940CEE0EAAQ55280886-7DE2CA4C-24A3-4C83-A277-120592EE10A6Q55496455-9EC1B31E-1EED-4362-B244-A4BEC06561F0Q55691752-5E43220A-0E78-41B7-B37B-1ABDD0D294E5Q57094242-67000C6C-FADD-42B6-ABC2-550D07C17F85
P2860
The platform trial: an efficient strategy for evaluating multiple treatments.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The platform trial: an efficient strategy for evaluating multiple treatments.
@en
The platform trial: an efficient strategy for evaluating multiple treatments.
@nl
type
label
The platform trial: an efficient strategy for evaluating multiple treatments.
@en
The platform trial: an efficient strategy for evaluating multiple treatments.
@nl
prefLabel
The platform trial: an efficient strategy for evaluating multiple treatments.
@en
The platform trial: an efficient strategy for evaluating multiple treatments.
@nl
P2093
P356
P1476
The platform trial: an efficient strategy for evaluating multiple treatments.
@en
P2093
Jason T Connor
Roger J Lewis
Scott M Berry
P304
P356
10.1001/JAMA.2015.2316
P407
P577
2015-04-01T00:00:00Z